Barkhof, Frederik <br/><br/>
Daclizumab in multiple sclerosis: a high-yield extension study.  [electronic resource] 

 -  The Lancet. Neurology  May 2014 
 - 443-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1474-4465 
<br/><br/><label>Standard No.: </label>10.1016/S1474-4422(14)70056-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Daclizumab<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy